P16INK4A Positively Regulates p21WAF1 Expression by suppressing AUF1-dependent mRNA decay

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Al Khalaf, Huda H ^a,b   Aboussekhra, Abdelilah ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING ABDULAZIZ CITY FOR SCIENCE AND TECHNOLOGY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; ENHANCED GREEN FLUORESCENT PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HYBRID PROTEIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; AUF1 GENE; BREAST EPITHELIUM; CANCER CELL; CDKN1A GENE; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN MCF 10A; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN STABILITY; REGULATORY MECHANISM; RNA DEGRADATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BRAIN MAPPING; CASE-CONTROL STUDIES; CELL PHYSIOLOGICAL PHENOMENA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; LONGITUDINAL STUDIES; MALE; MICE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEURAL NETWORKS (COMPUTER); NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; RATS;

EID: 84880726285     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070133     Document Type: Article

References (43)

1. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, et al. (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487-497. doi:10.1016/0092-8674(93)90136-E. PubMed: 8343202.
2. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, et al. (1999) The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18: 1571-1583. doi:10.1093/emboj/18.6.1571. PubMed: 10075928.
3. Ortega S, Malumbres M, Barbacid M, (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602: 73-87. PubMed: 11960696.
4. Bodner SM, Naeve CW, Rakestraw KM, Jones BG, Valentine VA, et al. (1999) Cloning and chromosomal localization of the gene encoding human cyclin D-binding Myb-like protein (hDMP1). Gene 229: 223-228. doi:10.1016/S0378-1119(98)00591-5. PubMed: 10095122.
5. Pei XH, Xiong Y, (2005) Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 24: 2787-2795. doi:10.1038/sj.onc.1208611. PubMed: 15838515.
6. Anderson WF, Chen BE, Brinton LA, Devesa SS, (2007) Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers. Cancer Causes Control 18: 1187-1198. doi:10.1007/s10552-007-9057-x. PubMed: 17823850.
7. Roninson IB, (2002) Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179: 1-14. doi:10.1016/S0304-3835(01)00847-3. PubMed: 11880176.
8. Gart et al,. (2006) Is p21 an oncogene? Mol Cancer Ther 5: 1385-1386. doi:10.1158/1535-7163.MCT-06-0163. PubMed: 16818495.
9. Gart et al,. (2009) p21(WAF1/CIP1) and cancer: a shifting paradigm? Biofactors 35: 161-164. doi:10.1002/biof.26. PubMed: 19449443.
10. Wang YA, Elson A, Leder P, (1997) Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc Natl Acad Sci U S A 94: 14590-14595. doi:10.1073/pnas.94.26.14590. PubMed: 9405657.
11. De la Cueva E, Garcia-Cao I, Herranz M, Lopez P, Garcia-Palencia P, et al. (2006) Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma. Oncogene 25: 4128-4132. doi:10.1038/sj.onc.1209432. PubMed: 16462758.
12. Serrano M, Hannon GJ, Beach D, (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707. doi:10.1038/366704a0. PubMed: 8259215.
13. Cannon-Albright LA, Goldgar DE, Neuhausen S, Gruis NA, Anderson DE, et al. (1994) Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171. Genomics 23: 265-268. doi:10.1006/geno.1994.1491. PubMed: 7829086.
14. Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee WC, et al. (1994) p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 54: 5547-5551. PubMed: 7923195.
15. Ruas M, Peters G, (1998) The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1378: F115-F177. PubMed: 9823374.
16. Bardeesy N, Sharpless NE, DePinho RA, Merlino G, (2001) The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model. Semin Cancer Biol 11: 201-218. doi:10.1006/scbi.2000.0371. PubMed: 11407945.
17. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A, (2001) Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413: 83-86. doi:10.1038/35092584. PubMed: 11544530.
18. Vogelstein B, Kinzler KW, (2004) Cancer genes and the pathways they control. Nat Med 10: 789-799. doi:10.1038/nm1087. PubMed: 15286780.
19. Mitra J, Dai CY, Somasundaram K, El-Deiry WS, Satyamoorthy K, et al. (1999) Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a). Mol Cell Biol 19: 3916-3928. PubMed: 10207115.
20. Parry D, Mahony D, Wills K, Lees E, (1999) Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol 19: 1775-1783. PubMed: 10022865.
21. Allan LA, Fried M, (1999) p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2os cells: p21waf1/Cip1 repression in Uv induced apoptosis. Oncogene 18: 5403-5412. doi:10.1038/sj.onc.1202931. PubMed: 10498894.
22. Al-Mohanna MA, Manogaran PS, Al-Mukhalafi Z, Al-Hussein AK, Aboussekhra A, (2004) The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin. Oncogene 23: 201-212. doi:10.1038/sj.onc.1206927. PubMed: 14712225.
23. Dotto, (2000). GP: pp. 21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 1471: M43-56.
24. Gart et al,., Tyner AL (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1: 639-649.
25. Al-Ansari MM, Hendrayani SF, Shehata AI, Aboussekhra A, (2012) p16(INK4A) Represses the paracrine tumor-promoting effects of breast stromal fibroblasts. Oncogene. doi:10.1038/onc.2012.270.
26. Aboussekhra A, (2011) Role of cancer-associated fibroblasts in breast cancer development and prognosis. Int J Dev Biol 55: 841-849. doi:10.1387/ijdb.113362aa. PubMed: 22161840.
27. Gart et al,. (2005) The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis. Leuk Res 29: 1237-1238. doi:10.1016/j.leukres.2005.04.023. PubMed: 15946739.
28. Gart et al, Goufman E, Tevosian SG, Shih H, Yee AS, et al. (1998) Activation and repression of p21(WAF1/CIP1) transcription by RB binding proteins. Oncogene 17: 3463-3469.
29. Li J, Poi MJ, Tsai MD, (2011) Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Biochemistry 50: 5566-5582. doi:10.1021/bi200642e. PubMed: 21619050.
30. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, et al. (2004) Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 23: 3092-3102. doi:10.1038/sj.emboj.7600305. PubMed: 15257295.
31. Wang W, Martindale JL, Yang X, Chrest FJ, Gorospe M, (2005) Increased stability of the p16 mRNA with replicative senescence. EMBO Rep 6: 158-164. doi:10.1038/sj.embor.7400346. PubMed: 15678155.
32. Al-Mohanna MA, Al-Khalaf HH, Al-Yousef N, Aboussekhra A, (2007) The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light. Nucleic Acids Res 35: 223-233. PubMed: 17158160.
33. Guo Z, Kumagai A, Wang SX, Dunphy WG, (2000) Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. Genes Dev 14: 2745-2756. doi:10.1101/gad.842500. PubMed: 11069891.
34. Bond JA, Haughton MF, Rowson JM, Smith PJ, Gire V, et al. (1999) Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis. Mol Cell Biol 19: 3103-3114. PubMed: 10082577.
35. Al-Haj L, Blackshear PJ, Khabar KS, (2012) Regulation of p21/CIP1/WAF-1 mediated cell-cycle arrest by RNase L and tristetraprolin, and involvement of AU-rich elements. Nucleic Acids Res 40: 7739-7752. doi:10.1093/nar/gks545. PubMed: 22718976.
36. McConnell BB, Gregory FJ, Stott FJ, Hara E, Peters G, (1999) Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol Cell Biol 19: 1981-1989. PubMed: 10022885.
37. Rowland BD, Peeper DS, (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6: 11-23. doi:10.1038/nrc1780. PubMed: 16372018.
38. Hawsawi NM, Ghebeh H, Hendrayani SF, Tulbah A, Al-Eid M, et al. (2008) Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. Cancer Res 68: 2717-2725. doi:10.1158/0008-5472.CAN-08-0192. PubMed: 18413739.
39. Fukushima K, Ueno Y, Yamagiwa Y, Yamakawa M, Iwasaki T, et al. (2001) Correlation between p21(waf1) and p16(INK4a) expression in hepatocellular carcinoma. Hepatol Res 20: 52-67. doi:10.1016/S1386-6346(00)00122-4. PubMed: 11282486.
40. Liao B, Hu Y, Brewer G, (2007) Competitive binding of AUF1 and TIAR to MYC mRNA controls its translation. Nat Struct Mol Biol 14: 511-518. doi:10.1038/nsmb1249. PubMed: 17486099.
41. Gart et al,., Ye X, Goufman E, Shianov P, Hay N, et al. (2001) Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci U S A 98: 4510-4515.
42. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, et al. (2001) Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413: 86-91. doi:10.1038/35092592. PubMed: 11544531.
43. Al-Khalaf HH, Colak D, Al-Saif M, Al-Bakheet A, Hendrayani SF, et al. (2011) p16(INK4a) positively regulates cyclin D1 and E2F1 through negative control of AUF1. PLOS ONE 6: e21111. doi:10.1371/journal.pone.0021111. PubMed: 21799732.